Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review. (2020)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2020-040644
PubMed Identifier: 32928868
Publication URI: http://europepmc.org/abstract/MED/32928868
Type: Journal Article/Review
Volume: 10
Parent Publication: BMJ open
Issue: 9
ISSN: 2044-6055